CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

31,93

11-июля-25 13:45:00

15 мин. задержка

Акции

-0,06

-0,19%

Сегодняшний диапазон

31,35 - 32,21

ISIN

N/A

Источник

NASDAQ

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

16 дек 2024 05:00:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 дек 2024 17:44:38 Источник Nasdaq GlobeNewswire
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

09 дек 2024 05:00:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

15 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

14 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

12 ноя 2024 13:07:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

12 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024

16 окт 2024 05:00:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 окт 2024 13:40:28 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

08 окт 2024 20:55:11 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

08 окт 2024 13:01:51 Источник Nasdaq GlobeNewswire
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

26 сен 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 сен 2024 13:40:25 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29 авг 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 авг 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 13:05:01 Источник Nasdaq GlobeNewswire
Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges

08 авг 2024 05:30:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

18 июл 2024 13:05:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 июл 2024 16:29:44 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.